Relay Therapeutics Inc Financial Flexibility Index
Relay Therapeutics Inc financial flexibility index. Relay Therapeutics Inc (RLAY) has a Financial Flexibility Index of -0.89x as of March 2026. Free cash flow of $-51.11 Million (operating CF $-51.11 Million minus capex $0.00) represents -1% of total liabilities ($57.43 Million). See cash generation quality of Relay Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Relay Therapeutics Inc (2018–2025)
Financial flexibility index of Relay Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Relay Therapeutics Inc across 8 annual periods. Check cash flow quality index of Relay Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Relay Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Relay Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Relay Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Relay Therapeutics Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.33x | $-235.04 Million | $-235.46 Million | $54.27 Million | ▼ -63.9% |
| 2024 | -2.64x | $-247.09 Million | $-249.11 Million | $93.50 Million | ▲ +17.9% |
| 2023 | -3.22x | $-296.19 Million | $-300.32 Million | $91.98 Million | ▼ -118.5% |
| 2022 | -1.47x | $-220.43 Million | $-229.49 Million | $149.55 Million | ▼ -129.9% |
| 2021 | -0.64x | $-70.94 Million | $-74.41 Million | $110.64 Million | ▲ +76.7% |
| 2020 | -2.75x | $-100.56 Million | $-102.49 Million | $36.54 Million | ▼ -2615.3% |
| 2019 | -0.10x | $-58.13 Million | $-66.13 Million | $573.51 Million | ▼ -28.8% |
| 2018 | -0.08x | $-42.45 Million | $-44.13 Million | $539.54 Million | — |